SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 97.59 |
| Enterprise Value ($M) | 126.15 |
| Book Value ($M) | 29.19 |
| Book Value / Share | 1.89 |
| Price / Book | 3.34 |
| NCAV ($M) | -17.03 |
| NCAV / Share | -1.10 |
| Price / NCAV | -5.73 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.16 |
| Return on Assets (ROA) | -0.37 |
| Return on Equity (ROE) | -0.91 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.83 |
| Current Ratio | 0.83 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 31.80 |
| Assets | 78.02 |
| Liabilities | 48.83 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 12.53 |
| Operating Income | -7.56 |
| Net Income | -6.25 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 1.78 |
| Cash from Investing | 5.85 |
| Cash from Financing | 6.09 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 21,372 | 92,040 | 23.22 | |
| 37,828 | 112,351 | 33.67 | |
| 61,307 | 268,399 | 22.84 | |
| 74,437 | 249,071 | 29.89 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AKBA – Akebia Therapeutics, Inc. | ALDX – Aldeyra Therapeutics, Inc. |
| ALGS – Aligos Therapeutics, Inc. | ALZN – Alzamend Neuro, Inc. |
| ANEB – Anebulo Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io